Literature DB >> 1624556

High-performance liquid chromatography of corynomycolic acids as a tool in identification of Corynebacterium species and related organisms.

D De Briel1, F Couderc, P Riegel, F Jehl, R Minck.   

Abstract

A high-performance liquid chromatography (HPLC) study of 307 strains of Corynebacterium species and related taxa revealed that strains classified as "Corynebacterium aquaticum"; "Corynebacterium asperum"; and Centers for Disease Control (CDC) groups 1, 2, A-3, A-4, A-5, B-1, B-3, E, F-2, and I-2 as well as some unidentified coryneforms do not contain any corynomycolic acids; therefore, they should not be included in the genus Corynebacterium. Such an HPLC method of identification permitted the correct assignment to the genus Rhodococcus of two unpigmented strains of coryneform bacteria whose mycolic acid profiles were comparable to those of Rhodococcus equi. Bacteria belonging to CDC groups ANF-1, ANF-3, F-1, G-1, G-2, and I-1, as well as some other Corynebacterium sp. strains, yielded corynomycolic acid HPLC patterns related to those of Corynebacterium species. Either similarities or differences were observed in the corynomycolic acid profiles of Corynebacterium species tested after culture on sheep blood agar and/or sheep blood agar supplemented with Tween 80, which demonstrated that identification at the species or group level is possible. However, Corynebacterium striatum and CDC group I-1 bacteria as well as CDC group G-1 and group G-2 bacteria had indistinguishable HPLC patterns. Conversely, some variations were observed within some species as Corynebacterium xerosis, C. striatum, and Corynebacterium minutissimum. The evaluation procedure of this HPLC method by mass spectrometry analysis of isolated eluted peaks revealed that analytical reverse-phase HPLC alone does not provide any structural information, since isomers with identical polarities coeluted as a single peak. Nevertheless, HPLC is a rapid and reliable method for identification of corynomycolic acid-containing bacteria in the clinical microbiological laboratory.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1624556      PMCID: PMC265301          DOI: 10.1128/jcm.30.6.1407-1417.1992

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  31 in total

1.  Septic arthritis and endocarditis due to group G-2 coryneform organism.

Authors:  A G Quinn; J S Comaish; S J Pedler
Journal:  Lancet       Date:  1991-07-06       Impact factor: 79.321

2.  Identification of mycobacteria by high-performance liquid chromatography.

Authors:  W R Butler; K C Jost; J O Kilburn
Journal:  J Clin Microbiol       Date:  1991-11       Impact factor: 5.948

3.  Free mycolic acids as criteria in the classification of Nocardia and the 'rhodochrous' complex.

Authors:  L Alashamaony; M Goodfellow; D E Minnikin
Journal:  J Gen Microbiol       Date:  1976-01

4.  High-performance liquid chromatography patterns of mycolic acids as criteria for identification of Mycobacterium chelonae, Mycobacterium fortuitum, and Mycobacterium smegmatis.

Authors:  W R Butler; J O Kilburn
Journal:  J Clin Microbiol       Date:  1990-09       Impact factor: 5.948

5.  Multiresistant corynebacteria in bacteriuria: a comparative study of the role of Corynebacterium group D2 and Corynebacterium jeikeium.

Authors:  D De Briel; J C Langs; G Rougeron; P Chabot; A Le Faou
Journal:  J Hosp Infect       Date:  1991-01       Impact factor: 3.926

6.  Vancomycin-resistant Corynebacterium species causing prosthetic valve endocarditis successfully treated with imipenem and ciprofloxacin.

Authors:  S Barnass; K Holland; S Tabaqchali
Journal:  J Infect       Date:  1991-03       Impact factor: 6.072

7.  Mass spectrometry as a tool for identifying group D2 corynebacteria by their fatty acid profiles.

Authors:  F Couderc; D De Briel; N Demont; V Gilard; J C Promé
Journal:  J Gen Microbiol       Date:  1991-08

8.  Cellular fatty acid composition as an adjunct to the identification of asporogenous, aerobic gram-positive rods.

Authors:  K A Bernard; M Bellefeuille; E P Ewan
Journal:  J Clin Microbiol       Date:  1991-01       Impact factor: 5.948

9.  Classification of coryneform bacteria associated with human urinary tract infection (group D2) as Corynebacterium urealyticum sp. nov.

Authors:  D Pitcher; A Soto; F Soriano; P Valero-Guillén
Journal:  Int J Syst Bacteriol       Date:  1992-01

10.  Contribution of high-performance liquid chromatography to the identification of some Corynebacterium species by comparison of their corynomycolic acid patterns.

Authors:  D De Briel; F Couderc; P Riegel; C Gallion; J C Langs; F Jehl
Journal:  Res Microbiol       Date:  1992-02       Impact factor: 3.992

View more
  16 in total

1.  Evaluation of the RapID CB plus system for identification of coryneform bacteria and Listeria spp.

Authors:  G Funke; K Peters; M Aravena-Roman
Journal:  J Clin Microbiol       Date:  1998-09       Impact factor: 5.948

2.  Sepsis due to multiply resistant Corynebacterium amycolatum.

Authors:  I de Miguel-Martinez; F Fernández-Fuertes; A Ramos-Macías; J M Bosch-Benitez; A M Martín-Sánchez
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1996-07       Impact factor: 3.267

3.  Most Corynebacterium xerosis strains identified in the routine clinical laboratory correspond to Corynebacterium amycolatum.

Authors:  G Funke; P A Lawson; K A Bernard; M D Collins
Journal:  J Clin Microbiol       Date:  1996-05       Impact factor: 5.948

4.  Isolation of Corynebacterium tuscaniae sp. nov. from blood cultures of a patient with endocarditis.

Authors:  Philippe Riegel; Roberta Creti; Romano Mattei; Alfredo Nieri; Christina von Hunolstein
Journal:  J Clin Microbiol       Date:  2006-02       Impact factor: 5.948

Review 5.  Clinical microbiology of coryneform bacteria.

Authors:  G Funke; A von Graevenitz; J E Clarridge; K A Bernard
Journal:  Clin Microbiol Rev       Date:  1997-01       Impact factor: 26.132

6.  Comparison of antimicrobial susceptibilities of Corynebacterium species by broth microdilution and disk diffusion methods.

Authors:  K Weiss; M Laverdière; R Rivest
Journal:  Antimicrob Agents Chemother       Date:  1996-04       Impact factor: 5.191

7.  Evidence of multiple taxa within commercially available reference strains of Corynebacterium xerosis.

Authors:  M B Coyle; R B Leonard; D J Nowowiejski; A Malekniazi; D J Finn
Journal:  J Clin Microbiol       Date:  1993-07       Impact factor: 5.948

8.  Coryneform bacteria isolated from middle ear fluid.

Authors:  M Simonet; D De Briel; I Boucot; R Minck; M Veron
Journal:  J Clin Microbiol       Date:  1993-06       Impact factor: 5.948

9.  Characteristics of CDC group 1 and group 1-like coryneform bacteria isolated from clinical specimens.

Authors:  G Funke; G M Lucchini; G E Pfyffer; M Marchiani; A von Graevenitz
Journal:  J Clin Microbiol       Date:  1993-11       Impact factor: 5.948

10.  Comparative chemotaxonomic studies of mycolic acid-free coryneform bacteria of human origin.

Authors:  C Barreau; F Bimet; M Kiredjian; N Rouillon; C Bizet
Journal:  J Clin Microbiol       Date:  1993-08       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.